دانلود کتاب انکولوژی توراسیک IASLC
IASLC Thoracic Oncology, 2ed

Contents

۱. Classical Epidemiology
۲. Tobacco Control and Primary Prevention
۳. Tobacco Cessation
۴. Non-Smoking Related Lung Cancer
۵. Gender-Related Differences in Lung Cancer
۶. Genetic Susceptibility to Lung Cancer
۷. Early Detection and Radiologic Screening
۸. Preclinical Biomarkers for The Early Detection of Lung Cancer
۹. Chemoprevention of Lung Cancer: Present and Developing Technologies
۱۰. Copy Number Abnormalities and Gene Rearrangements in Lung Cancer: Present and Developing Technologies
۱۱. Mutational Events in Lung Cancer: Present and Developing Technologies
۱۲. Epigenetic Events, Alterations, and Remodeling in Lung Cancer: Present and Developing Technologies
۱۳. Stem Cells and Lung Cancer: In Vitro and In Vivo Studies
۱۴. Microenvironment and Lung Cancer
۱۵. MicroRNAs as Biomarkers for Lung Cancer
۱۶. Humoral and Cellular Immune Dysregulation and Lung Cancer
۱۷. Classic Anatomic Pathology and Lung Cancer
۱۸. Molecular Testing and Lung Cancer
۱۹. Management of the Small Biopsy in the Molecular Er
۲۰. Clinical Presentation
۲۱. Conventional Imaging Lung Cancer
۲۲. PET Imaging of Lung Cancer
۲۳. Diagnostic Work-Up of Suspected Lung Cancer
۲۴. Surgical Staging of the Mediastinum including Mediastinoscopy and Thoracoscopy, Preoperative and Intraoperative
۲۵. The 8th Edition of the Tumor, Node and Metastasis Classification of Lung Cancer
۲۶. Preoperative Functional Evaluation of the Surgical Candidate
۲۷. Results of Video Assisted Techniques for Resection of Lung Cancer
۲۸. Results of Robotic Techniques for Resection of Lung Cancer
۲۹. Extent of Surgical Resection for Stage I and II Lung Cancer
۳۰. Extended Resections for Lung Cancer: Chest Wall and Pancoast Tumors
۳۱. Extended Resections for Lung Cancer: Broncho/Vascular Sleeve Resections
۳۲. Multiple Nodules: Management of the Patient with Synchronous or Metachronous Lung Cancers
۳۳. Surgical Management of the Marginally Resectable Patient
۳۴. Technical Requirements for Lung Cancer Radiotherapy
۳۵. Radiobiology of Lung Cancer
۳۶. Patient Selection for Radiotherapy
۳۷. Stage I Non-Small Cell Lung Cancer and Oligometastatic Disease
۳۸. Ablation Options for Localized Lung Cancer
۳۹. Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer, including Combined Modality
۴۰. Radiotherapy in the Management of Small Cell Lung Cancer: Thoracic Radiotherapy, Prophylactic Cranial Irradiation
۴۱. Palliative Radiotherapy for Lung Cancer: Locoregional and Metastatic
۴۲. Acute and Late Toxicities of Thoracic Radiotherapy: Pulmonary, Esophagus, Heart
۴۳. Treatment-Related Neurotoxicity, Medical and Radiation Therapy
۴۴. Front-Line Systemic Options in Non-Small Cell Lung Cancer
۴۵. Systemic Options in Second Line and Beyond
۴۶. Maintenance Therapy in NSCLC
۴۷. Pharmacogenomics and Lung Cancer
۴۸. New Targetable Pathways in Lung Cancer
۴۹. Management of Toxicities of Targeted Therapies
۵۰. Immunotherapy and Lung Cancer
۵۱. Systemic Therapy in Early-Stage NSCLC
۵۲. Treatment of Small-Cell Lung Cancer
۵۳. Malignant Mesothelioma
۵۴. Mediastinal Tumors
۵۵. Neuroendocrine Tumors of the Lung Other than SCLC
۵۶. Thymic Cancer/Thymoma
۵۷. Lung Cancer Emergencies
۵۸. Role of Palliative Care in Lung Cancer
۵۹. Methodology of Clinical Trials in Lung Cancer
۶۰. How to Promote and Organize Clinical Research in Lung Cancer
۶۱. Role of Advocacy Groups in Lung Cancer
۶۲. Health Services Research in Lung Cancer
۶۳. Appendix: Diagnostic Algorithms